Cargando…
Transdermal delivery of Minoxidil using HA-PLGA nanoparticles for the treatment in alopecia
BACKGROUND: Alopecia has become a very common disease that many people around the world are suffered. Minoxidil (MXD) is the most well-known commercialized drug in its treatment. However, in the case of MXD administration, there are some problems with low efficiency of transdermal delivery and addit...
Autores principales: | Jeong, Woo Yeup, Kim, Sodam, Lee, So Yun, Lee, Hyeseon, Han, Dong Wook, Yang, Seung Yun, Kim, Ki Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824046/ https://www.ncbi.nlm.nih.gov/pubmed/31695925 http://dx.doi.org/10.1186/s40824-019-0164-z |
Ejemplares similares
-
Treatment of traction alopecia with oral minoxidil
por: Kim, Sa Rang, et al.
Publicado: (2022) -
Nitric oxide synergizes minoxidil delivered by transdermal hyaluronic acid liposomes for multimodal androgenetic-alopecia therapy()()
por: Xing, Hui, et al.
Publicado: (2023) -
Recent advances in transdermal drug delivery systems: a review
por: Jeong, Woo Yeup, et al.
Publicado: (2021) -
Effect of Oral Minoxidil for Alopecia: Systematic Review
por: do Nascimento, Israel Junior Borges, et al.
Publicado: (2020) -
New Target for Minoxidil in the Treatment of Androgenetic Alopecia
por: Shen, Yuqing, et al.
Publicado: (2023)